Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-18 Scadden David Director Exercise or conversion +2,816 20,419
2026-06-18 Scadden David Director Exercise or conversion · Restricted stock units −2,816 0
2026-06-18 Scadden David Director Grant or award · Restricted stock units +2,927 2,927
2026-06-18 Scadden David Director Grant or award · Stock options (right to buy) +14,950 14,950
2025-11-12 Scadden David Director Exercise or conversion 10b5-1 +200 $18.09 $4K 17,803
2025-11-12 Scadden David Director Sale 10b5-1 −200 $43.84 $9K 17,603
2025-11-12 Scadden David Director Exercise or conversion · Stock options (right to buy) 10b5-1 −200 26,907
2025-10-08 Scadden David Director Exercise or conversion 10b5-1 +200 $18.09 $4K 17,803
2025-10-08 Scadden David Director Sale 10b5-1 −200 $41.00 $8K 17,603
2025-10-08 Scadden David Director Exercise or conversion · Stock options (right to buy) 10b5-1 −200 27,107
2025-09-30 Scadden David Director Exercise or conversion 10b5-1 +200 $18.09 $4K 17,803
2025-09-30 Scadden David Director Sale 10b5-1 −200 $40.00 $8K 17,603
2025-09-30 Scadden David Director Exercise or conversion · Stock options (right to buy) 10b5-1 −200 27,307
2025-08-27 Scadden David Director Exercise or conversion 10b5-1 +200 $18.09 $4K 17,803
2025-08-27 Scadden David Director Sale 10b5-1 −200 $40.00 $8K 17,603
2025-08-27 Scadden David Director Exercise or conversion · Stock options (right to buy) 10b5-1 −200 27,507
2025-07-10 Scadden David Director Exercise or conversion 10b5-1 +1,400 $18.09 $25K 19,003
2025-07-10 Scadden David Director Sale 10b5-1 −1,400 $40.00 $56K 17,603
2025-07-10 Scadden David Director Exercise or conversion · Stock options (right to buy) 10b5-1 −1,400 27,707
2025-06-20 Scadden David Director Exercise or conversion +2,120 17,603

Page 1 of 3 · 55 trades